feed,title,long_url,short_url
gNews,This Is the Biggest Risk With Iovance Biotherapeutics Stock - The Motley Fool,https://news.google.com/rss/articles/CBMijwFBVV95cUxOTFI5Ym1EYmpGajVNQ0hIanNveU8zY3dyNEhyQzRlOWFPQkQxWVhkVnQ0TlFKTWo3WEhLQWJSVndaNTUyTVVTeW9lZ3RXblV5NnJSamFOdTRKT0hXR0U3MVgtVnlWWWw4SnBCd015NFlVbDdDNXRRVjdjQVJjaWlRX3VadmV5eGFpWnVjS0N6MA?oc=5,https://da.gd/rlUw
